The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Diagnostic Testing of STDs Market Research Report 2024
Synopsis
Sexually Transmitted Diseases (STDs) spread primarily through person-to-person sexual contacts. Varied testing technologies used for the identification and analysis of the STD contracted comprise the definition of ‘diagnostic testing of STDs’.
The global Diagnostic Testing of STDs market was valued at US$ 92360 million in 2023 and is anticipated to reach US$ 130390 million by 2030, witnessing a CAGR of 4.6% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Diagnostic Testing of STDs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diagnostic Testing of STDs.
Report Scope
The Diagnostic Testing of STDs market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Diagnostic Testing of STDs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Diagnostic Testing of STDs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
Abbott
Becton Dickinson
BioMerieux
Danaher
Hologic
Segment by Type
Chlamydia testing
Gonorrhea testing
P&S Syphilis testing
HPV testing
HSV testing
HIV testing
Chancroid testing
Segment by Application
Hospitals
Clinics
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Diagnostic Testing of STDs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Diagnostic Testing of STDs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Sexually Transmitted Diseases (STDs) spread primarily through person-to-person sexual contacts. Varied testing technologies used for the identification and analysis of the STD contracted comprise the definition of ‘diagnostic testing of STDs’.
The global Diagnostic Testing of STDs market was valued at US$ 92360 million in 2023 and is anticipated to reach US$ 130390 million by 2030, witnessing a CAGR of 4.6% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Diagnostic Testing of STDs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diagnostic Testing of STDs.
Report Scope
The Diagnostic Testing of STDs market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Diagnostic Testing of STDs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Diagnostic Testing of STDs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
Abbott
Becton Dickinson
BioMerieux
Danaher
Hologic
Segment by Type
Chlamydia testing
Gonorrhea testing
P&S Syphilis testing
HPV testing
HSV testing
HIV testing
Chancroid testing
Segment by Application
Hospitals
Clinics
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Diagnostic Testing of STDs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Diagnostic Testing of STDs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Diagnostic Testing of STDs Market Overview
1.1 Product Overview and Scope of Diagnostic Testing of STDs
1.2 Diagnostic Testing of STDs Segment by Type
1.2.1 Global Diagnostic Testing of STDs Market Value Comparison by Type (2024-2030)
1.2.2 Chlamydia testing
1.2.3 Gonorrhea testing
1.2.4 P&S Syphilis testing
1.2.5 HPV testing
1.2.6 HSV testing
1.2.7 HIV testing
1.2.8 Chancroid testing
1.3 Diagnostic Testing of STDs Segment by Application
1.3.1 Global Diagnostic Testing of STDs Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Clinics
1.4 Global Diagnostic Testing of STDs Market Size Estimates and Forecasts
1.4.1 Global Diagnostic Testing of STDs Revenue 2019-2030
1.4.2 Global Diagnostic Testing of STDs Sales 2019-2030
1.4.3 Global Diagnostic Testing of STDs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Diagnostic Testing of STDs Market Competition by Manufacturers
2.1 Global Diagnostic Testing of STDs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Diagnostic Testing of STDs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Diagnostic Testing of STDs Average Price by Manufacturers (2019-2024)
2.4 Global Diagnostic Testing of STDs Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Diagnostic Testing of STDs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Diagnostic Testing of STDs, Product Type & Application
2.7 Diagnostic Testing of STDs Market Competitive Situation and Trends
2.7.1 Diagnostic Testing of STDs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Diagnostic Testing of STDs Players Market Share by Revenue
2.7.3 Global Diagnostic Testing of STDs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Diagnostic Testing of STDs Retrospective Market Scenario by Region
3.1 Global Diagnostic Testing of STDs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Diagnostic Testing of STDs Global Diagnostic Testing of STDs Sales by Region: 2019-2030
3.2.1 Global Diagnostic Testing of STDs Sales by Region: 2019-2024
3.2.2 Global Diagnostic Testing of STDs Sales by Region: 2025-2030
3.3 Global Diagnostic Testing of STDs Global Diagnostic Testing of STDs Revenue by Region: 2019-2030
3.3.1 Global Diagnostic Testing of STDs Revenue by Region: 2019-2024
3.3.2 Global Diagnostic Testing of STDs Revenue by Region: 2025-2030
3.4 North America Diagnostic Testing of STDs Market Facts & Figures by Country
3.4.1 North America Diagnostic Testing of STDs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Diagnostic Testing of STDs Sales by Country (2019-2030)
3.4.3 North America Diagnostic Testing of STDs Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Diagnostic Testing of STDs Market Facts & Figures by Country
3.5.1 Europe Diagnostic Testing of STDs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Diagnostic Testing of STDs Sales by Country (2019-2030)
3.5.3 Europe Diagnostic Testing of STDs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Diagnostic Testing of STDs Market Facts & Figures by Country
3.6.1 Asia Pacific Diagnostic Testing of STDs Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Diagnostic Testing of STDs Sales by Country (2019-2030)
3.6.3 Asia Pacific Diagnostic Testing of STDs Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Diagnostic Testing of STDs Market Facts & Figures by Country
3.7.1 Latin America Diagnostic Testing of STDs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Diagnostic Testing of STDs Sales by Country (2019-2030)
3.7.3 Latin America Diagnostic Testing of STDs Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Diagnostic Testing of STDs Market Facts & Figures by Country
3.8.1 Middle East and Africa Diagnostic Testing of STDs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Diagnostic Testing of STDs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Diagnostic Testing of STDs Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Diagnostic Testing of STDs Sales by Type (2019-2030)
4.1.1 Global Diagnostic Testing of STDs Sales by Type (2019-2024)
4.1.2 Global Diagnostic Testing of STDs Sales by Type (2025-2030)
4.1.3 Global Diagnostic Testing of STDs Sales Market Share by Type (2019-2030)
4.2 Global Diagnostic Testing of STDs Revenue by Type (2019-2030)
4.2.1 Global Diagnostic Testing of STDs Revenue by Type (2019-2024)
4.2.2 Global Diagnostic Testing of STDs Revenue by Type (2025-2030)
4.2.3 Global Diagnostic Testing of STDs Revenue Market Share by Type (2019-2030)
4.3 Global Diagnostic Testing of STDs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Diagnostic Testing of STDs Sales by Application (2019-2030)
5.1.1 Global Diagnostic Testing of STDs Sales by Application (2019-2024)
5.1.2 Global Diagnostic Testing of STDs Sales by Application (2025-2030)
5.1.3 Global Diagnostic Testing of STDs Sales Market Share by Application (2019-2030)
5.2 Global Diagnostic Testing of STDs Revenue by Application (2019-2030)
5.2.1 Global Diagnostic Testing of STDs Revenue by Application (2019-2024)
5.2.2 Global Diagnostic Testing of STDs Revenue by Application (2025-2030)
5.2.3 Global Diagnostic Testing of STDs Revenue Market Share by Application (2019-2030)
5.3 Global Diagnostic Testing of STDs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Roche
6.1.1 Roche Corporation Information
6.1.2 Roche Description and Business Overview
6.1.3 Roche Diagnostic Testing of STDs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Roche Diagnostic Testing of STDs Product Portfolio
6.1.5 Roche Recent Developments/Updates
6.2 Abbott
6.2.1 Abbott Corporation Information
6.2.2 Abbott Description and Business Overview
6.2.3 Abbott Diagnostic Testing of STDs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Abbott Diagnostic Testing of STDs Product Portfolio
6.2.5 Abbott Recent Developments/Updates
6.3 Becton Dickinson
6.3.1 Becton Dickinson Corporation Information
6.3.2 Becton Dickinson Description and Business Overview
6.3.3 Becton Dickinson Diagnostic Testing of STDs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Becton Dickinson Diagnostic Testing of STDs Product Portfolio
6.3.5 Becton Dickinson Recent Developments/Updates
6.4 BioMerieux
6.4.1 BioMerieux Corporation Information
6.4.2 BioMerieux Description and Business Overview
6.4.3 BioMerieux Diagnostic Testing of STDs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 BioMerieux Diagnostic Testing of STDs Product Portfolio
6.4.5 BioMerieux Recent Developments/Updates
6.5 Danaher
6.5.1 Danaher Corporation Information
6.5.2 Danaher Description and Business Overview
6.5.3 Danaher Diagnostic Testing of STDs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Danaher Diagnostic Testing of STDs Product Portfolio
6.5.5 Danaher Recent Developments/Updates
6.6 Hologic
6.6.1 Hologic Corporation Information
6.6.2 Hologic Description and Business Overview
6.6.3 Hologic Diagnostic Testing of STDs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Hologic Diagnostic Testing of STDs Product Portfolio
6.6.5 Hologic Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Diagnostic Testing of STDs Industry Chain Analysis
7.2 Diagnostic Testing of STDs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Diagnostic Testing of STDs Production Mode & Process
7.4 Diagnostic Testing of STDs Sales and Marketing
7.4.1 Diagnostic Testing of STDs Sales Channels
7.4.2 Diagnostic Testing of STDs Distributors
7.5 Diagnostic Testing of STDs Customers
8 Diagnostic Testing of STDs Market Dynamics
8.1 Diagnostic Testing of STDs Industry Trends
8.2 Diagnostic Testing of STDs Market Drivers
8.3 Diagnostic Testing of STDs Market Challenges
8.4 Diagnostic Testing of STDs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
